Marwan G. Fakih, MD, explains the implications of the findings from the phase 2 trial of balstilimab plus botensilimab for the treatment of patients with microsatellite stable metastatic colorectal ...

In recent years, interest in neoadjuvant therapy strategies for localized colorectal cancer has increased—especially treatment with immunotherapies. At ASCO meeting 2024, updated data on 6‑month ...

At the ASCO 2024, four clinically very important abstracts in endometrial cancer were presented. Long-term survival for primary hormonal therapy in premenopausal patients with clinical stage I disease ...

10 luxury brand logos have mastered it. They've become more than marks on products—they're cultural touchstones, over decades and continents. Logos are stories we tell ourselves. The best ones?

and 1-3L+ metastatic cancer at ASCO-GI, which took place January 23-25, H.C. Wainwright tells investors. Agenus provided updated survival metrics for the NEST study evaluating neoadjuvant bot/bal ...

Lessons From Taxanes Versus Eribulin for First-Line Metastatic Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer in the EMERALD Study ASCO Guidelines provide recommendations with ...

Want to brand your business without breaking the bank? The best free logo maker will be an essential tool in your marketing kit - and after testing these completely free logo designers ...

Logo makers typically employ a drag-and-drop interface, so all you need to do is select vector graphics, choose a color, and move them into position. If you're brand-new to logo design (or you ...

Shares of Exelixis (EXEL) are moving lower after the American Society of Clinical Oncology released an abstract on data for zanzalintinib alone or in combination with atezolizumab in patients with ...

As the 2025 American Society of Clinical Oncology Gastrointestinal Cancers (ASCO GI) Symposium approaches, community oncologists can expect a wealth of new data that ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

ASCO 2023: Timing of PARP Inhibition for Prostate Cancer with Defects in Homologous Recombination Repair ASCO 2023: A Multi-Center Natural History Study of Precision-Based Genomics in Prostate Cancer ...